Internalization of CD59 appears to be cholesterol-dependent, and MAC deposition on ECs in IH is reversed by statins in a CD59-dependent manner, suggesting a possible therapeutic strategy to reduce vascular risk in OSA. The gene discussed is CD59; the disease is obstructive sleep apnea syndrome.